Treatment of chronic or relapsing COVID-19 in immunodeficiency

BACKGROUND: Patients with some types of immunodeficiency can experience chronic or relapsing infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). This leads to morbidity and mortality, infection control challenges, and the risk of evolution of novel viral variants. The optima...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Li-An K., Moran, Ed, Goodman, Anna, Baxendale, Helen, Bermingham, William, Buckland, Matthew, AbdulKhaliq, Iman, Jarvis, Hannah, Hunter, Michael, Karanam, Surendra, Patel, Aisha, Jenkins, Megan, Robbins, Alexander, Khan, Sujoy, Simpson, Thomas, Jolles, Stephen, Underwood, Jonathan, Savic, Sinisa, Richter, Alex, Shields, Adrian, Brown, Michael, Lowe, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2022
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585958/
https://www.ncbi.nlm.nih.gov/pubmed/34780850
http://dx.doi.org/10.1016/j.jaci.2021.10.031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585958/
https://www.ncbi.nlm.nih.gov/pubmed/34780850
http://dx.doi.org/10.1016/j.jaci.2021.10.031

Ejemplares similares